Interestingly, the respective (% MFI) values (G0/G1-S and S-G2/M) for the pre-treated with BFA (T24) cells were measured as 32.2% and 24.6%, respectively, thereby indicating that TRBP2 is not transported extra-cellularly in urothelial-carcinoma settings. This evidence concerns the gene TARBP2 and urothelial carcinoma.